Cargando…

A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias

Detalles Bibliográficos
Autores principales:	van Vuren, Annelies J., Sharfo, Alaa, Grootendorst, Simon T., van Straaten, Stephanie, Punt, Arjen M., Petersen, Jesper B., El Fassi, Daniel, van Solinge, Wouter W., Bartels, Marije, van Wijk, Richard, Glenthøj, Andreas, van Beers, Eduard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357262/ https://www.ncbi.nlm.nih.gov/pubmed/34396049 http://dx.doi.org/10.1097/HS9.0000000000000627

Ejemplares similares

The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance
por: Grootendorst, Simon, et al.
Publicado: (2021)

A Unique Monocyte Transcriptome Discriminates Sickle Cell Disease From Other Hereditary Hemolytic Anemias and Shows the Particular Importance of Lipid and Interferon Signaling
por: van Vuren, Annelies J., et al.
Publicado: (2021)

Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent
por: Tomczyk, Maja, et al.
Publicado: (2020)

Erythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism
por: Coffey, Richard, et al.
Publicado: (2018)

Dynamics of Erythroferrone Response to Erythropoietin in Rats
por: Xu, Peng, et al.
Publicado: (2022)

The Complexity of Genotype-Phenotype Correlations in Hereditary Spherocytosis: A Cohort of 95 Patients: Genotype-Phenotype Correlation in Hereditary Spherocytosis
por: van Vuren, Annelies, et al.
Publicado: (2019)

Red blood cell vesiculation in hereditary hemolytic anemia
por: Alaarg, Amr, et al.
Publicado: (2013)

Iron overload in patients with rare hereditary hemolytic anemia: Evidence‐based suggestion on whom and how to screen
por: van Straaten, Stephanie, et al.
Publicado: (2018)

Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics
por: Skrypnik, Katarzyna, et al.
Publicado: (2020)

The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry
por: Castro-Mollo, Melanie, et al.
Publicado: (2021)

A Proposed Concept for Defective Mitophagy Leading to Late Stage Ineffective Erythropoiesis in Pyruvate Kinase Deficiency
por: van Vuren, Annelies Johanna, et al.
Publicado: (2021)

Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice
por: Coffey, Richard, et al.
Publicado: (2018)

Transfusion burden in early childhood plays an important role in iron overload in Diamond‐Blackfan anaemia
por: de Wilde, Jonathan R. A., et al.
Publicado: (2022)

Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure
por: Robach, Paul, et al.
Publicado: (2020)

Liver Iron Retention Estimated from Utilization of Oral and Intravenous Radioiron in Various Anemias and Hemochromatosis in Humans
por: van Vuren, Annelies J., et al.
Publicado: (2020)

Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant
por: Pirotte, Michelle, et al.
Publicado: (2021)

Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo‐controlled randomized cross‐over clinical trial
por: van Vuren, Annelies, et al.
Publicado: (2022)

Metabolic Fingerprint in Hereditary Spherocytosis Correlates With Red Blood Cell Characteristics and Clinical Severity
por: van Dooijeweert, Birgit, et al.
Publicado: (2021)

Characterization of Erythroferrone in a Teleost Fish (Dicentrarchus labrax) With Two Functional Hepcidin Types: More Than an Erythroid Regulator
por: Neves, João V., et al.
Publicado: (2022)

The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research
por: van Vuren, Annelies J., et al.
Publicado: (2019)

P1566: PROTON PUMP INHIBITION FOR SECONDARY HEMOCHROMATOSIS IN HEREDITARY ANEMIA, A PHASE III PLACEBO-CONTROLLED RANDOMIZED CROSS-OVER CLINICAL TRIAL
por: Van Vuren, A., et al.
Publicado: (2022)

Dried blood spot metabolomics reveals a metabolic fingerprint with diagnostic potential for Diamond Blackfan Anaemia
por: van Dooijeweert, Birgit, et al.
Publicado: (2021)

Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents
por: Inomata, Shinjiro, et al.
Publicado: (2019)

A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels
por: Lira Zidanes, Acaynne, et al.
Publicado: (2020)

Untargeted metabolic profiling in dried blood spots identifies disease fingerprint for pyruvate kinase deficiency
por: van Dooijeweert, Birgit, et al.
Publicado: (2020)

Effect of Recombinant Human Erythroferrone Protein on Hepcidin Gene (Hamp1) Expression in HepG2 and HuH7 Cells
por: Than, Min Min, et al.
Publicado: (2021)

Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias
por: Al-Samkari, Hanny, et al.
Publicado: (2021)

P1424: ONE-YEAR FOLLOW-UP OF A PHASE 2 STUDY OF MITAPIVAT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR THE TREATMENT OF SICKLE CELL DISEASE
por: van Dijk, Myrthe, et al.
Publicado: (2023)

Editorial: Pathophysiology of Rare Hemolytic Anemias
por: van Wijk, Richard, et al.
Publicado: (2020)

P1481: SYSTEMATICALLY REDUCED RED CELL PHOSPHATIDYLSERINE FLIPPASE ACTIVITY IS SUFFICIENT TO INDUCE HEREDITARY HEMOLYTIC ANEMIA
por: van Dijk, Myrthe, et al.
Publicado: (2023)

IDENTIFICATION OF ERYTHROFERRONE AS AN ERYTHROID REGULATOR OF IRON METABOLISM
por: Kautz, Léon, et al.
Publicado: (2014)

Physical Training Increases Erythroferrone Levels in Men
por: Dziembowska, Inga, et al.
Publicado: (2021)

Normal range and predictors of serum erythroferrone in infants
por: Bäckström, Fredrik, et al.
Publicado: (2023)

The Levels of Hepcidin and Erythropoietin in Pregnant Women with Anemia of Various Geneses
por: Vazenmiller, Dmitriy, et al.
Publicado: (2018)

Characterization of erythroferrone oligomerization and its impact on BMP antagonism
por: Mast, Jacob F, et al.
Publicado: (2023)

GATA-1 Defects in Diamond–Blackfan Anemia: Phenotypic Characterization Points to a Specific Subset of Disease
por: van Dooijeweert, Birgit, et al.
Publicado: (2022)

Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone
por: Diepeveen, Laura, et al.
Publicado: (2021)

Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis
por: Berrevoets, M. C., et al.
Publicado: (2021)

AG-348 (mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and adenosine triphosphate levels over a broad range of PKLR genotypes
por: Rab, Minke A.E., et al.
Publicado: (2020)

Lactate dehydrogenase to carboxyhemoglobin ratio as a biomarker of heme release to heme processing is associated with higher tricuspid regurgitant jet velocity and early death in sickle cell disease
por: van Vuren, Annelies J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ddv9eejiia94o4e75jc6r879cv